Yahoo Web Search

Search results

1. INVO Bioscience, Inc.

   NasdaqCM: INVO

   0.9290

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.0560 (-5.69%)

   At close:4:00 PM EDTMon. May 20, 2024

   0.9201 -0.01 (-0.96%)

   After hrs:7:12 PM EDTMon. May 20, 2024

   Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	0.9600
     High	0.9603
     Low	0.9200

   • Mkt Cap	3.53M
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	0.9850
     52 Wk. Low	0.5000
     52 Wk. High	8.6000

   More about INVO

   Related stocks

   • PALI
     Palisade Bio, Inc.
     PALI
     5.85
     -8.02%
   • PXMD
     PaxMedica, Inc.
     PXMD
     0.2239
     -6.74%
   • CDIO
     Cardio Diagnostics Holdings, Inc.
     CDIO
     0.6901
     -5.47%
   • SPRC
     SciSparc Ltd.
     SPRC
     1.2200
     0.00%
   • ABVC
     ABVC BioPharma, Inc.
     ABVC
     1.0800
     +0.93%

   More on Yahoo Finance

2. People also ask

   How has INVO performed in the first quarter 2024?

   • Management Commentary "We are pleased with the progress we have made at INVO, reporting record first quarter 2024 revenue with growth of 353% compared to the first quarter of 2023, and a substantial $1.2 million improvement in our adjusted EBITDA,” commented Steve Shum, CEO of INVO.

   INVO Reports Record First Quarter 2024 Financial Results

   markets.businessinsider.com/news/stocks/invo-reports-record-first-quarter-2024-financial-results-1033386680

   See all results for this question

   What happens if Naya Biosciences merges with INVO?

   • Under the terms of the agreement, NAYA Biosciences' shareholders would receive 7.3333 shares of INVO for each share of NAYA Biosciences at closing, for a total of approximately 18,150,000 shares of INVO. Following the closing of the Merger, the combined company is expected to operate under the name "NAYA Biosciences."

   INVO Reports Record First Quarter 2024 Financial Results

   markets.businessinsider.com/news/stocks/invo-reports-record-first-quarter-2024-financial-results-1033386680

   See all results for this question

   Where can I find information about invobio?

   • For more information, please visit www.invobio.com. Safe Harbor Statement This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.

   INVO Reports Record First Quarter 2024 Financial Results

   markets.businessinsider.com/news/stocks/invo-reports-record-first-quarter-2024-financial-results-1033386680

   See all results for this question

3. finance.yahoo.com › quote › INVOINVO Bioscience, Inc. (INVO) Latest Stock News & Headlines ...

   finance.yahoo.com › quote › INVO

   • Cached

   INVO. -4.46%. Get the latest INVO Bioscience, Inc. (INVO) stock news and headlines to help you in your trading and investing decisions.

4. www.google.com › finance › quoteInvo Bioscience Inc (INVO) Stock Price & News - Google Finance

   www.google.com › finance › quote

   • Cached

   Get the latest Invo Bioscience Inc (INVO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

5. seekingalpha.com › symbol › INVOINVO Bioscience, Inc. (INVO) Stock Price, Quote, News ...

   seekingalpha.com › symbol › INVO

   • Cached

   4 days ago · INVO Bioscience, Inc. (INVO) Stock Price, Quote, News & Analysis. Good decisions require good information. Find hidden gems and smart strategies from top experts when you join Seeking...

   • Company name: Aethlon Medical, Inc.
   • Industry: Health Care Equipment

   • Employees: 15
   • Market Cap: 3.83M

6. www.globenewswire.com › news-release › 2024/05/15INVO Reports Record First Quarter 2024 Financial Results

   www.globenewswire.com › news-release › 2024/05/15

   • Cached

   5 days ago · CONTACT. INVO Bioscience: Steve Shum 978-878-9505 sshum@invobio.com. INVO Investor Contact: Robert Blum (Lytham Partners, LLC) 602-889-9700 INVO@lythampartners.com

7. www.prnewswire.com › news-releases › invo-bioscienceINVO Bioscience and NAYA Biosciences Announce Definitive ...

   www.prnewswire.com › news-releases › invo-bioscience

   • Cached

   Oct 23, 2023 · The merger target valuation is $12,373,780 for INVO and $90,750,000 for NAYA, based on a target stock price of $5.00 per share.

8. stockanalysis.com › stocks › invoINVO Bioscience, Inc. (INVO) Stock Price, Quote & News ...

   stockanalysis.com › stocks › invo

   • Cached

   6 days ago · SARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatme... 11 hours ago - GlobeNewsWire. INVO Reports Fourth Quarter and Full Year 2023 Financial Results.